No Data
No Data
TD Cowen Maintains Cellebrite(CLBT.US) With Buy Rating, Cuts Target Price to $27
Cellebrite to Report First-Quarter 2025 Financial Results on May 14, 2025
Investors Still Waiting For A Pull Back In Cellebrite DI Ltd. (NASDAQ:CLBT)
William Blair Maintains Cellebrite(CLBT.US) With Buy Rating
Cellebrite DI: Strong Long-Term Growth Potential Amid Market Challenges
10 Winners Awarded "Justies" at Cellebrite's First-Ever Digital Justice Awards
Chalet : it dip down to 19. dont be sad.